ABOUT US
Learn more about us.
The Bitterman Lab is a research group within the AI in Medicine Program at Mass General Brigham and the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Harvard Medical School. We are a multidisciplinary team focused on clinical natural language processing and AI safety and oversight in healthcare. While broadly interested in the healthcare domain, we apply our expertise in clinical oncology to develop AI methods that improve cancer patients' experiences and outcomes.
Our current areas of active research include:
- Large language model evaluation and scalable oversight for healthcare.
- Automated data mining from the electronic health records to accelerate cancer care and research.
- Applying natural language processing advances to enhance health literacy and patient-provider communication.
- Translational AI: Clinical trials of AI and frameworks for ethical, patient-centered AI implementation.
Learn more about our Research, Publications, and Team.
The Bitterman lab is grateful to recieve funding for our research from the NIH/NCI, the American Cancer Society (ACS), the American Society for Radiation Oncology (ASTRO), and the American Association for Cancer Research (AACR).
Danielle Bitterman, MD
Principal Investigator
Assistant Professor, Harvard Medical School